儿童配方和技术发展之外的挑战:在5毫克普莱马奎因片中的杂质的识别和in silico合格
Thamara Carvalho Mendes1, Maria Eduarda Correia Furtado1, Juliana Johansson Soares Medeiros2
1Laboratório de Desenvolvimento e Validação Analítica - Farmanguinhos, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.
Journal of pharmaceutical and biomedical analysis
|April 18, 2025
概括
本研究详细介绍了primaquine 5 mg片的分析方法,识别和合格的杂质用于儿科使用注册. 该研究强调了分析开发在确保药物产品质量和安全方面的重要性.
科学领域:
- 制药化学 制药化学 制药化学
- 分析化学 分析化学
- 药物开发 药物开发
背景情况:
- 对于儿科药品的监管批准需要严格的分析表征.
- 适用于儿科的Primaquine 5mg片需要进行全面的稳定性研究.
- 识别和鉴定杂质对于确保药物的安全性和有效性至关重要.
研究的目的:
- 建立一个关键的分析程序,用于注册用于儿科的primaquine 5mg片.
- 在长期稳定性研究中检测到的杂质的识别和合格.
- 确保对儿科药物产品的监管指南的遵守.
主要方法:
- 使用C18列进行稳定性指示色谱分离.
- 使用二进制移动相的梯度化 (TFA 0.05%和酸).
- 通过二极管阵列探测器 (DAD) 在265nm和液体染色学-高分辨率质谱法 (LC-HRMS) 进行检测.
主要成果:
- 在24个月后,两个降解产品 (DP-2和DP-3) 在识别极限被检测到.
- LC-HRMS分析为DP-2 (C30H41O2N6) 和DP-3 (C26H29N4O4) 提供了元素组成.
- 根据in silico安全评估,DP-2获得了0.6%的规格资格;DP-3获得了0.5%的规格.
结论:
- 开发的分析程序对于评估儿科注册用皮马奎因片的质量和安全性至关重要.
- 强调了药物产品生命周期分析开发的挑战.
- 强大的分析方法对于满足监管标准和确保患者安全至关重要.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
101
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
101
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
41
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
41
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
242
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
242
Factors Influencing Drug Absorption: Drug Dissolution
372
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
372


